Ocular Therapeutix, Inc. (OCUL)
USD 8.44
(-6.43%)
USD 8.44
(-6.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 58.44 Million | 51.49 Million | 43.52 Million | 17.4 Million | 4.22 Million | 1.99 Million |
| Cost of Revenue | 5.28 Million | 4.54 Million | 4.4 Million | 2.08 Million | 2.32 Million | 465 Thousand |
| Gross Profit | 53.16 Million | 46.95 Million | 39.11 Million | 15.32 Million | 1.9 Million | 1.52 Million |
| Operating Expenses | 135.54 Million | 125.6 Million | 117.15 Million | 78.16 Million | 87.7 Million | 60.64 Million |
| Selling, General and Administrative Expenses | 74.48 Million | 72.14 Million | 67.07 Million | 49.47 Million | 46.61 Million | 23.72 Million |
| Research and Development Expenses | 61.05 Million | 53.46 Million | 50.08 Million | 28.69 Million | 41.09 Million | 36.91 Million |
| Other Expenses | - | -1000.00 | 1000.00 | - | -8000.00 | - |
| Cost and Expenses | 140.82 Million | 130.14 Million | 121.55 Million | 80.25 Million | 90.02 Million | 61.1 Million |
| Operating Income | -82.38 Million | -78.65 Million | -78.03 Million | -62.84 Million | -85.8 Million | -59.11 Million |
| Interest Expense | 11.33 Million | 7.02 Million | 6.67 Million | 6.76 Million | 6.1 Million | 1.73 Million |
| Income Tax Expense | - | -7.61 Million | 4.25 Million | 3.99 Million | 3.56 Million | -2.28 Million |
| Earnings before Tax | -80.73 Million | -71.03 Million | -6.55 Million | -155.63 Million | -86.37 Million | -59.97 Million |
| Net Income | -80.73 Million | -63.42 Million | -10.8 Million | -159.63 Million | -89.93 Million | -57.69 Million |
| Earnings Per Share Basic | -1.09 | -0.83 | -0.14 | -2.63 | -1.99 | -1.51 |
| Earnings Per Share Diluted | -1.02 | -0.83 | -0.13 | -2.63 | -1.99 | -1.51 |
| Weighted Average Shares Outstanding | 79.82 Million | 76.87 Million | 76.39 Million | 60.75 Million | 45.27 Million | 38.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 85.59 Million | 76.87 Million | 82.16 Million | 60.75 Million | 45.27 Million | 38.11 Million |
| Gross Margin | 0.91 | 0.91 | 0.90 | 0.88 | 0.45 | 0.77 |
| EBIT Margin | -1.14 | -1.51 | -1.79 | -3.60 | -20.01 | -29.27 |
| Profit Margin | -1.38 | -1.23 | -0.25 | -9.17 | -21.28 | -28.99 |
| EBITDA | -66.41 Million | -61.9 Million | -75.61 Million | -146.09 Million | -77.74 Million | -55.95 Million |
| Earnings Before Tax Margin | -1.41 | -1.53 | -1.79 | -3.61 | -20.30 | -29.71 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 16.44 Million | 14.71 Million | 58.44 Million | 14.8 Million | 14.95 Million | 15.18 Million |
| Cost of Revenue | 1.5 Million | 1.32 Million | 5.28 Million | 1.38 Million | 1.37 Million | 1.3 Million |
| Gross Profit | 14.93 Million | 13.38 Million | 53.16 Million | 13.41 Million | 13.57 Million | 13.88 Million |
| Operating Expenses | 58.52 Million | 45.06 Million | 135.54 Million | 33.46 Million | 32.91 Million | 34.45 Million |
| Selling, General and Administrative Expenses | 29.66 Million | 24.33 Million | - | 17.27 Million | 17.89 Million | 19.35 Million |
| Research and Development Expenses | 28.85 Million | 20.73 Million | - | 16.19 Million | 15.01 Million | 15.09 Million |
| Other Expenses | -28.85 Million | - | -1000.00 | 1000.00 | - | - |
| Cost and Expenses | 60.03 Million | 46.39 Million | 140.82 Million | 34.85 Million | 34.29 Million | 35.75 Million |
| Operating Income | -43.59 Million | -31.61 Million | -82.38 Million | -20.04 Million | -19.21 Million | -20.57 Million |
| Interest Expense | 3.19 Million | -4.05 Million | 11.33 Million | 4.15 Million | -3.42 Million | 1.99 Million |
| Income Tax Expense | - | -920 Thousand | 2.81 Million | -7.18 Million | -890 Thousand | 1.99 Million |
| Earnings before Tax | -43.77 Million | -64.84 Million | -80.73 Million | -29.22 Million | -516 Thousand | -20.68 Million |
| Net Income | -43.77 Million | -64.84 Million | -80.73 Million | -29.22 Million | -516 Thousand | -20.68 Million |
| Earnings Per Share Basic | -0.26 | -0.49 | - | -0.35 | -0.01 | -0.26 |
| Earnings Per Share Diluted | -0.26 | -0.49 | - | -0.35 | -0.01 | -0.26 |
| Weighted Average Shares Outstanding | 165.82 Million | 132.02 Million | 79.82 Million | 84.42 Million | 79.37 Million | 78.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 165.82 Million | 132.02 Million | 85.59 Million | 84.42 Million | 85.14 Million | 78.04 Million |
| Gross Margin | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 |
| EBIT Margin | -2.59 | -2.15 | - | -1.29 | -1.29 | -1.26 |
| Profit Margin | -2.66 | -4.41 | -1.38 | -1.97 | -0.03 | -1.36 |
| EBITDA | -42.63 Million | -31.61 Million | - | -19.09 Million | -19.21 Million | -19.17 Million |
| Earnings Before Tax Margin | -2.65 | -2.15 | -1.41 | -1.35 | -1.29 | -1.35 |
NUAG
CHSTY
NS6
DUKB
RVV
ASY